Plasmablastic Lymphoma-A Crosstalk Between Myeloma and Lymphoma

Area of Science:

• Hematology
• Oncology
• Pathology

Background:

• Plasmablastic lymphoma (PBL) is a rare, aggressive subtype of large B-cell lymphoma.
• PBL predominantly affects immunocompromised individuals, frequently associated with Human Immunodeficiency Virus (HIV) and Epstein-Barr Virus (EBV).
• Diagnostic challenges arise from overlapping features with multiple myeloma and other large B-cell lymphomas.

Purpose of the Study:

• To provide a comprehensive overview of plasmablastic lymphoma.
• To explore clinical features, diagnostic criteria, and treatment strategies for PBL.
• To highlight recent advancements in managing this rare hematologic malignancy.

Main Methods:

• Literature review of clinical studies, case reports, and pathological analyses.
• Synthesis of information on epidemiology, clinical presentation, and diagnostic modalities.
• Analysis of current and emerging therapeutic approaches for PBL.

Main Results:

• PBL commonly involves the gastrointestinal tract, lymph nodes, oral mucosa, and skin.
• Diagnosis requires careful integration of clinical, pathological, and molecular findings.
• Treatment outcomes vary, necessitating tailored therapeutic strategies.

Conclusions:

• Accurate and timely diagnosis of PBL is crucial for effective management.
• Multidisciplinary approaches are essential for optimizing patient care and outcomes.
• Further research is needed to develop more targeted therapies for plasmablastic lymphoma.